TEVA - CIK 0000818686
The table below shows TEVA PHARMACEUTICAL INDUSTRIES LTD's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.74B | $2.20B | $2.16B | $1.70B | $3.32B | $2.26B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $3.39B | $3.81B | $3.56B | $3.38B | $3.46B | $3.77B |
| Inventory | $3.18B | $3.32B | $3.50B | $3.25B | $3.96B | $3.93B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $13.71B |
| $12.74B |
| $12.62B |
| $11.53B |
| $12.31B |
| $11.63B |
| Property, plant & equipment | $4.00B | $4.82B | $4.81B | $4.63B | $5.67B | $5.57B |
| Goodwill | $15.82B | $15.95B | $15.95B | $15.48B | $16.12B | $16.49B |
| Total assets | $40.04B | $39.86B | $40.13B | $38.41B | $41.76B | $41.34B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $13.53B | $11.49B | $11.86B | $11.16B | $13.80B | $13.04B |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $31.81B | $32.60B | $33.30B | $32.15B | $35.38B | $34.77B |
| Retained earnings | -$13.39B | -$14.24B | -$14.68B | -$14.96B | -$14.96B | -$14.52B |
| Total equity | $8.23B | $7.25B | $6.83B | $6.26B | $6.07B | $6.36B |